TerrAscend Corp. (
CSE: C.TER,
Forum) stated on Thursday that it has formed a joint venture with
Cistron Corp. to launch
Ascendant Laboratories Inc., a science and innovation company dedicated to advancing plant biology for the cannabinoid market. The transaction is valued at approximately $1.7 million (CDN).
For more information on this news, click
here.
TerrAscend recently released its
Q1 2018 financial results was highlighting operating cash flow at $4.1 Million compared to $0.9 million for the prior year period.
FULL DISCLOSURE: TerrAscend Corp. is a paid client of Stockhouse Publishing.